20 November 2024
CVS Group
plc
("CVS" or
the "Company")
Result of
AGM
CVS, one of
the UK's leading providers of integrated veterinary
services, announces that at the Company's Annual General Meeting
("AGM") held earlier today, all of the resolutions proposed, as set
out in the Notice of AGM, were passed on a poll. Resolutions
1 to 13 were passed as ordinary resolutions and resolutions 14 to
17 were passed as special resolutions.
A summary of proxy votes received
for each resolution will shortly be available alongside the Notice
of AGM on the Company's website, https://www.cvsukltd.co.uk/investor-centre/agm
CVS
Group plc
via Camarco
Richard Fairman, CEO
Scott Morrison, Group Company
Secretary
Peel Hunt LLP (Nominated Adviser & Broker)
+44 (0)20 7418
8900
Christopher Golden / James Steel /
Andrew Clark / Lalit Bose
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran
Walsh / Milo Bonser
Camarco (Financial
PR)
Geoffrey Pelham-Lane
+44 (0)7733 124 226
Ginny Pulbrook
+44 (0)7961 315
138
About CVS Group plc
(www.cvsukltd.co.uk)
CVS Group is an AIM-listed
provider of veterinary services with operations in the UK, and
Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and
dedicated clinical teams and support colleagues at the core of its
strategy.
The Group now operates c.460
veterinary practices across its two territories, including
specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates
Laboratories (providing diagnostic services to CVS and third
parties), Crematoria (providing pet cremation and clinical waste
disposal for CVS and third-party practices) and an online retail
business ("Animed Direct").
The Group employs c.9,000 personnel,
including c.2,400 veterinary surgeons and c.3,300
nurses.